Pharmas expect strong Q3 income; Dealmaking heats up in vaccine market;

> Despite the lagging economy, times are fine for pharmaceutical companies. Three of the biggest are announcing their Q3 earnings this week, and their numbers are expected to look good. FiercePharma

> Of late, the vaccine market has become one of the hottest niches in biopharma. Lately, that's led to a string of big M&A deals, and will probably spawn several more, experts say. FierceVaccines

> Though healthcare financial indicators are getting better, many construction projects are still mothballed, and it's not clear when building will begin again. FierceHealthFinance

> Given how widely treatments vary from child to child, building a pediatric HIT system can be an extremely complex project. Still, that's just the challenge Children's Hospital of Boston took on recently. FierceHealthIT

And Finally... Don't, and I mean don't, come between a teenager and their cellphone. That is, unless you don't mind getting your butt kicked. Article